UPDATE 1-Depomed sues India's Lupin for patent infringement

NYMEX-Crude up in choppy trade as dollar supports

UPDATE 2-FDA holds up Merck KGaA's multiple sclerosis pill

UPDATE 1-Atlantic Power to raise C$75 mln in bought deal

BRIEF-Mosaic announces segment realignment, phosphate asset write-offs

REFILE-UPDATE 1-FDA doesn't approve cladribine pills -Merck KGaA

UPDATE 1-FDA doesn't approve cladribine tablets - Merck KGaA

BRIEF-Atlantic Power announces C$75 mln bought deal financing

UPDATE 1-Shell, India's Essar extend refinery deal talks

Japan Hot Stocks-DeNA, Toto, Miyazaki Bank, Sumitomo Corp

RESEARCH ALERT-Citigroup ratings(Nov 30)

New WHO guidelines urge phaseout of major HIV drug

Countries should phase out the use of stavudine, the most common AIDS drug, because of "long-term, irreversible" side effects in HIV patients including wasting and a nerve disorder, the World Health Organization said on Monday.

Bennett contract increased, stock shoots higher

UPDATE 1-DSM still targets divestments by end-2010